Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: short-term outcomes of a multicenter, phase II study (OGSG1902). - Tanaka R; Endo S; Yamaguchi T; Miyagaki H; Kawada J; Omori T; Takahashi N; Masuzawa T; Furukawa H; Sato Y; Takeno A; Shinno N; et al. (Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2025)